Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 phylodynamics differentiates the effectiveness of non-pharmaceutical interventions

View ORCID ProfileJean-Philippe Rasigade, View ORCID ProfileAnaïs Barray, View ORCID ProfileJulie Teresa Shapiro, View ORCID ProfileCharlène Coquisart, View ORCID ProfileYoann Vigouroux, View ORCID ProfileAntonin Bal, View ORCID ProfileGrégory Destras, View ORCID ProfilePhilippe Vanhems, View ORCID ProfileBruno Lina, View ORCID ProfileLaurence Josset, View ORCID ProfileThierry Wirth
doi: https://doi.org/10.1101/2020.08.24.20180927
Jean-Philippe Rasigade
1CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Lyon 69007, France
2Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon 69004, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jean-Philippe Rasigade
  • For correspondence: jean-philippe.rasigade@univ-lyon1.fr wirth@mnhn.fr
Anaïs Barray
1CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Lyon 69007, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anaïs Barray
Julie Teresa Shapiro
1CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Lyon 69007, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julie Teresa Shapiro
Charlène Coquisart
3Institut de Systématique, Evolution, Biodiversité (ISYEB), Muséum national d’Histoire naturelle, CNRS, Sorbonne Université, Université des Antilles, EPHE, Paris 75005, France
4PSL University, EPHE, Paris 75014, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Charlène Coquisart
Yoann Vigouroux
3Institut de Systématique, Evolution, Biodiversité (ISYEB), Muséum national d’Histoire naturelle, CNRS, Sorbonne Université, Université des Antilles, EPHE, Paris 75005, France
4PSL University, EPHE, Paris 75014, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yoann Vigouroux
Antonin Bal
1CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Lyon 69007, France
2Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon 69004, France
5Centre National de Référence des Virus Respiratoires, Hospices Civils de Lyon, Lyon 69004, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Antonin Bal
Grégory Destras
1CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Lyon 69007, France
2Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon 69004, France
5Centre National de Référence des Virus Respiratoires, Hospices Civils de Lyon, Lyon 69004, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Grégory Destras
Philippe Vanhems
1CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Lyon 69007, France
6Service d’Hygiène, Epidémiologie, Infectiovigilance et Prévention, Hospices Civils de Lyon (HCL), Lyon 69008, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philippe Vanhems
Bruno Lina
1CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Lyon 69007, France
2Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon 69004, France
5Centre National de Référence des Virus Respiratoires, Hospices Civils de Lyon, Lyon 69004, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bruno Lina
Laurence Josset
1CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Lyon 69007, France
2Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon 69004, France
5Centre National de Référence des Virus Respiratoires, Hospices Civils de Lyon, Lyon 69004, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laurence Josset
Thierry Wirth
3Institut de Systématique, Evolution, Biodiversité (ISYEB), Muséum national d’Histoire naturelle, CNRS, Sorbonne Université, Université des Antilles, EPHE, Paris 75005, France
4PSL University, EPHE, Paris 75014, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thierry Wirth
  • For correspondence: jean-philippe.rasigade@univ-lyon1.fr wirth@mnhn.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Quantifying the effectiveness of large-scale non-pharmaceutical interventions against COVID-19 is critical to adapting responses against future waves of the pandemic. By combining phylogenetic data of 5,198 SARS-CoV-2 genomes with the chronology of non-pharmaceutical interventions in 57 countries, we examine how interventions and combinations thereof alter the divergence rate of viral lineages, which is directly related to the epidemic reproduction number. Home containment and education lockdown had the largest independent impacts and were predicted to reduce the reproduction number by 35% and 26%, respectively. However, we find that in contexts with a reproduction number >2, no individual intervention is sufficient to stop the epidemic and increasingly stringent intervention combinations may be required. Our phylodynamic approach can complement epidemiological models to inform public health strategies against COVID-19.

Competing Interest Statement

BL is currently active in groups advising the French government for which BL is not receiving payment.

Funding Statement

JPR received support from the FINOVI Foundation (grant R18037CC).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Corresponding author corrected. Supplementary information merged with the manuscript file.

Data Availability

Both data and analysis code are available online at https://github.com/rasigadelab/covid-npi.

https://github.com/rasigadelab/covid-npi

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 27, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 phylodynamics differentiates the effectiveness of non-pharmaceutical interventions
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 phylodynamics differentiates the effectiveness of non-pharmaceutical interventions
Jean-Philippe Rasigade, Anaïs Barray, Julie Teresa Shapiro, Charlène Coquisart, Yoann Vigouroux, Antonin Bal, Grégory Destras, Philippe Vanhems, Bruno Lina, Laurence Josset, Thierry Wirth
medRxiv 2020.08.24.20180927; doi: https://doi.org/10.1101/2020.08.24.20180927
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 phylodynamics differentiates the effectiveness of non-pharmaceutical interventions
Jean-Philippe Rasigade, Anaïs Barray, Julie Teresa Shapiro, Charlène Coquisart, Yoann Vigouroux, Antonin Bal, Grégory Destras, Philippe Vanhems, Bruno Lina, Laurence Josset, Thierry Wirth
medRxiv 2020.08.24.20180927; doi: https://doi.org/10.1101/2020.08.24.20180927

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1095)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9766)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1557)
  • Health Policy (734)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11639)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1175)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4654)
  • Radiology and Imaging (776)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)